查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1593858

活细胞封装市场：依技术、聚合物、应用分类 - 2025-2030 年全球预测

Live Cell Encapsulation Market by Techniques (Coaxial Airflow, Electrostatic Dripping, Jet Cutting), Polymer (2-Hydroxyethyl Methacrylate & Methyl Methacrylate, Alginate, Cellulose Sulfate), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年活细胞封装市场价值为3.1229亿美元，预计到2024年将达到3.2589亿美元，复合年增长率为4.44%，预计到2030年将达到4.2354亿美元。

活细胞封装是一种生物医学技术，将活细胞封装在半透膜或胶囊中，允许分子交换，同时保护它们免受宿主免疫系统的影响。该技术具有多种医疗应用的潜力，包括细胞疗法、再生医学和药物传输系统。其主要需求源自于其为移植细胞提供免疫保护的能力，这对于治疗糖尿病、癌症、神经退化性疾病等至关重要。其应用范围广泛，包括研究和治疗实践，其中封装细胞用于释放治疗剂、细胞替代疗法和创建生物人工器官。最终用途部分主要包括专注于先进治疗方法的医院、研究机构和製药公司。

主要市场统计
基准年[2023] 31229万美元
预测年份 [2024] 32589万美元
预测年份 [2030] 42354万美元
复合年增长率（%） 4.44%

推动市场成长的关键因素包括生物技术和医疗保健的投资增加、生物材料和生物相容性的进步以及需要创新治疗方法的慢性疾病的盛行率上升。同时，意识的提高和医疗保健支出的增加正在推动进一步的需求。然而，生物相容性、扩充性和监管障碍等挑战是主要限制。市场开拓公司必须克服高昂的研发成本和维持胶囊内细胞活力的复杂性。

潜在的商机在于开发更复杂的生物材料和封装技术、个人化医疗以及将实验室进展转化为临床实践的产学合作。人们对活细胞封装在食品和食品领域的潜力也越来越感兴趣。公司应专注于奈米封装和生物分解性聚合物等创新领域。研究表明，在持续研究和对先进治疗的需求不断增长的推动下，市场正趋于中高速成长。策略伙伴关係和强有力的监管策略对于克服现有挑战至关重要。市场是充满活力的，主要由技术进步和对创新治疗方法的明确需求推动，创造了一个充满希望但竞争激烈的格局。

市场动态：快速发展的活细胞封装市场的关键市场洞察

供需的动态交互作用正在改变活细胞封装市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 白喉、破伤风、小儿麻痹、脊髓灰质炎、结核病等目标疾病发生率上升。
    • 透过公共和私人投资来支持新产品开发和技术进步
    • 社会对封装细胞在疾病管理中临床作用的认识
  • 市场限制因素
    • 生产成本高
  • 市场机会
    • 关注新的药物输送系统
    • 正在进行的活细胞封装开发研究活动
  • 市场挑战
    • 替代疗法的可用性和采用

波特五力：驾驭活细胞封装市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解活细胞封装市场的外部影响

外部宏观环境因素在塑造活细胞封装市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解活细胞封装市场的竞争格局

对活细胞封装市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵活细胞封装市场供应商绩效评估

FPNV定位矩阵是评估活细胞封装市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了活细胞封装市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对活细胞封装市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 白喉、破伤风、小儿麻痹、脊髓灰质炎和结核病等目标疾病的发生率增加。
      • 透过公共和私人投资支持新产品开发与技术创新相结合的投资
      • 大众对封装细胞在疾病管理中临床作用的认识
    • 抑制因素
      • 生产成本高
    • 机会
      • 专注于新型药物输送系统
      • 正在进行的活细胞封装开发研究活动
    • 任务
      • 替代疗法的可用性和采用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章活细胞封装市场技术

  • 同轴气流
  • 由于静电而滴落
  • 喷射切割
  • 液体喷射拆卸
  • 旋转盘喷雾
  • 简单的滴水
  • 振动喷射技术

第七章活细胞封装市场聚合物

  • 甲基丙烯酸2-羟乙酯和甲基丙烯酸甲酯
  • 海藻酸
  • 硫酸纤维素
  • 几丁聚醣
  • PAN-PVC
  • 硅质胶囊

第八章活细胞封装市场：依应用

  • 细胞移植
  • 药物输送
  • 益生菌
  • 再生医学
  • 调查

第九章北美和南美活细胞封装市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太活细胞封装市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲活细胞封装市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Austrianova Singapore Pte Ltd
  • Beta-O2 Technologies Ltd.
  • Biotime, Inc.
  • Blacktrace Holdings Ltd.
  • BUCHI Labortechnik AG
  • Defymed SAS
  • Evonik Industries AG
  • Kadimastem
  • Living Cell Technologies Limited.
  • Merck KGaA
  • Neurotech Holdings, LLC.
  • Pharmacyte Biotech, Inc.
  • Reed Pacific Pty Limited
  • Sernova Corporation
  • Sigilon Therapeutics, Inc.
  • Viacyte, Inc.
Product Code: MRR-437517DB6D5D

The Live Cell Encapsulation Market was valued at USD 312.29 million in 2023, expected to reach USD 325.89 million in 2024, and is projected to grow at a CAGR of 4.44%, to USD 423.54 million by 2030.

Live cell encapsulation is a biomedical technology where live cells are enclosed within semi-permeable membranes or capsules, protecting them from the host's immune system while allowing the exchange of molecules. This technique holds potential in various medical applications such as cell therapy, regenerative medicine, and drug delivery systems. Its primary necessity stems from its ability to provide immune protection to transplanted cells, which is crucial for treating conditions like diabetes, cancer, and neurodegenerative diseases. The application scope is broad, involving research and therapeutic practice, where encapsulated cells can be used to release therapeutic agents, offer cell replacement therapy, and create bioartificial organs. End-use segments primarily include hospitals, research institutes, and pharmaceutical companies focusing on advanced therapeutic methods.

KEY MARKET STATISTICS
Base Year [2023] USD 312.29 million
Estimated Year [2024] USD 325.89 million
Forecast Year [2030] USD 423.54 million
CAGR (%) 4.44%

Key factors driving market growth include increasing investments in biotechnology and healthcare, advancements in biomaterials and biocompatibility, and the rising prevalence of chronic diseases requiring innovative treatment modalities. Simultaneously, growing awareness and healthcare expenditure are spurring further demand. However, challenges such as biological compatibility, scalability, and regulatory hurdles pose significant limitations. Market players must navigate high research and development costs and the complexity of maintaining cell viability within capsules.

Potential opportunities lie in developing more sophisticated biomaterials and encapsulation techniques, personalized medicine, and collaborations between industry and academia to translate laboratory advancements into clinical settings. There's also a growing interest in the potential of live cell encapsulation in food and nutraceutical sectors. Businesses should focus on areas of innovation like nanoencapsulation and biodegradable polymers. Insights suggest a market leaning towards moderate to high-growth trends, driven by continuous research and the burgeoning demand for advanced therapies. Strategic partnerships and robust regulatory strategies will be critical for overcoming existing challenges. The market is dynamic, primarily propelled by technological advances and a clear demand for innovative treatment methods, ensuring a promising yet competitive landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Live Cell Encapsulation Market

The Live Cell Encapsulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of target diseases including target diseases, diphtheria, tetanus, poliomyelitis, measles, and tuberculosis
    • Investment via public-private investments to support the novel product development coupled with technology advancements
    • Public awareness related to the clinical role of encapsulated cells in disease management
  • Market Restraints
    • High production cost
  • Market Opportunities
    • Focus on Novel drug delivery systems
    • Ongoing research activities for development of live cell encapsulation
  • Market Challenges
    • Availability and adoption of alternative therapies

Porter's Five Forces: A Strategic Tool for Navigating the Live Cell Encapsulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Live Cell Encapsulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Live Cell Encapsulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Live Cell Encapsulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Live Cell Encapsulation Market

A detailed market share analysis in the Live Cell Encapsulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Live Cell Encapsulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Live Cell Encapsulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Live Cell Encapsulation Market

A strategic analysis of the Live Cell Encapsulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Live Cell Encapsulation Market, highlighting leading vendors and their innovative profiles. These include Austrianova Singapore Pte Ltd, Beta-O2 Technologies Ltd., Biotime, Inc., Blacktrace Holdings Ltd., BUCHI Labortechnik AG, Defymed SAS, Evonik Industries AG, Kadimastem, Living Cell Technologies Limited., Merck KGaA, Neurotech Holdings, LLC., Pharmacyte Biotech, Inc., Reed Pacific Pty Limited, Sernova Corporation, Sigilon Therapeutics, Inc., and Viacyte, Inc..

Market Segmentation & Coverage

This research report categorizes the Live Cell Encapsulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Techniques, market is studied across Coaxial Airflow, Electrostatic Dripping, Jet Cutting, Liquid-Jet Break-Up, Rotating Disk Atomization, Simple Dripping, and Vibrating-Jet Technique.
  • Based on Polymer, market is studied across 2-Hydroxyethyl Methacrylate & Methyl Methacrylate, Alginate, Cellulose Sulfate, Chitosan, PAN-PVC, and Siliceous Encapsulates.
  • Based on Application, market is studied across Cell Transplantation, Drug Delivery, Probiotics, Regenerative Medicine, and Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of target diseases including target diseases, diphtheria, tetanus, poliomyelitis, measles, and tuberculosis
      • 5.1.1.2. Investment via public-private investments to support the novel product development coupled with technology advancements
      • 5.1.1.3. Public awareness related to the clinical role of encapsulated cells in disease management
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus on Novel drug delivery systems
      • 5.1.3.2. Ongoing research activities for development of live cell encapsulation
    • 5.1.4. Challenges
      • 5.1.4.1. Availability and adoption of alternative therapies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Live Cell Encapsulation Market, by Techniques

  • 6.1. Introduction
  • 6.2. Coaxial Airflow
  • 6.3. Electrostatic Dripping
  • 6.4. Jet Cutting
  • 6.5. Liquid-Jet Break-Up
  • 6.6. Rotating Disk Atomization
  • 6.7. Simple Dripping
  • 6.8. Vibrating-Jet Technique

7. Live Cell Encapsulation Market, by Polymer

  • 7.1. Introduction
  • 7.2. 2-Hydroxyethyl Methacrylate & Methyl Methacrylate
  • 7.3. Alginate
  • 7.4. Cellulose Sulfate
  • 7.5. Chitosan
  • 7.6. PAN-PVC
  • 7.7. Siliceous Encapsulates

8. Live Cell Encapsulation Market, by Application

  • 8.1. Introduction
  • 8.2. Cell Transplantation
  • 8.3. Drug Delivery
  • 8.4. Probiotics
  • 8.5. Regenerative Medicine
  • 8.6. Research

9. Americas Live Cell Encapsulation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Live Cell Encapsulation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Live Cell Encapsulation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Austrianova Singapore Pte Ltd
  • 2. Beta-O2 Technologies Ltd.
  • 3. Biotime, Inc.
  • 4. Blacktrace Holdings Ltd.
  • 5. BUCHI Labortechnik AG
  • 6. Defymed SAS
  • 7. Evonik Industries AG
  • 8. Kadimastem
  • 9. Living Cell Technologies Limited.
  • 10. Merck KGaA
  • 11. Neurotech Holdings, LLC.
  • 12. Pharmacyte Biotech, Inc.
  • 13. Reed Pacific Pty Limited
  • 14. Sernova Corporation
  • 15. Sigilon Therapeutics, Inc.
  • 16. Viacyte, Inc.

LIST OF FIGURES

  • FIGURE 1. LIVE CELL ENCAPSULATION MARKET RESEARCH PROCESS
  • FIGURE 2. LIVE CELL ENCAPSULATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. LIVE CELL ENCAPSULATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. LIVE CELL ENCAPSULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LIVE CELL ENCAPSULATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LIVE CELL ENCAPSULATION MARKET DYNAMICS
  • TABLE 7. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY COAXIAL AIRFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY ELECTROSTATIC DRIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY JET CUTTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY LIQUID-JET BREAK-UP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY ROTATING DISK ATOMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY SIMPLE DRIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY VIBRATING-JET TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY 2-HYDROXYETHYL METHACRYLATE & METHYL METHACRYLATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY ALGINATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY CELLULOSE SULFATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY PAN-PVC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY SILICEOUS ENCAPSULATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY CELL TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 72. PHILIPPINES LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 75. SINGAPORE LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 78. SOUTH KOREA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 81. TAIWAN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 84. THAILAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 87. VIETNAM LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 94. DENMARK LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 97. EGYPT LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 100. FINLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 103. FRANCE LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 106. GERMANY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 109. ISRAEL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 112. ITALY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 115. NETHERLANDS LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 118. NIGERIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 121. NORWAY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 124. POLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 127. QATAR LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 130. RUSSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 133. SAUDI ARABIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 139. SPAIN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 142. SWEDEN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 145. SWITZERLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 148. TURKEY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED ARAB EMIRATES LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
  • TABLE 154. UNITED KINGDOM LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. LIVE CELL ENCAPSULATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 156. LIVE CELL ENCAPSULATION MARKET, FPNV POSITIONING MATRIX, 2023